Gupta A K, Sarin G S
Br J Ophthalmol. 1984 Apr;68(4):242-4. doi: 10.1136/bjo.68.4.242.
The serum alpha-1 antitrypsin level was measured in 60 patients with endogenous uveitis, 27 patients with phacoallergic endophthalmitis, 12 patients with phacolytic glaucoma, and 58 healthy subjects. Thirty-four patients with endogenous uveitis were also followed up for 6 months after treatment, and the serum alpha-1 antitrypsin level was measured again. There was a significant rise in the serum alpha-1 antitrypsin level in cases of endogenous uveitis and phacoallergic endophthalmitis but no alteration in cases of phacolytic glaucoma. Among the patients with endogenous uveitis the level was significantly raised in cases of anterior uveitis, but there was no change in cases of posterior uveitis. A significant rise was seen only in cases of acute anterior uveitis but not in chronic anterior uveitis. The serum alpha-1 antitrypsin level was unaltered in endogenous uveitis despite clinical improvement.
对60例内因性葡萄膜炎患者、27例晶状体过敏性眼内炎患者、12例晶状体溶解性青光眼患者及58名健康受试者测定血清α-1抗胰蛋白酶水平。对34例内因性葡萄膜炎患者治疗后随访6个月,并再次测定血清α-1抗胰蛋白酶水平。内因性葡萄膜炎和晶状体过敏性眼内炎患者血清α-1抗胰蛋白酶水平显著升高,而晶状体溶解性青光眼患者血清α-1抗胰蛋白酶水平无变化。在内因性葡萄膜炎患者中,前葡萄膜炎患者的血清α-1抗胰蛋白酶水平显著升高,而后葡萄膜炎患者则无变化。仅急性前葡萄膜炎患者血清α-1抗胰蛋白酶水平显著升高,慢性前葡萄膜炎患者则无变化。尽管临床症状改善,但内因性葡萄膜炎患者的血清α-1抗胰蛋白酶水平未改变。